Skip to content
The Policy VaultThe Policy Vault

LunestaCigna

insomnia

Preferred products

  • generic eszopiclone tablets
  • generic ramelteon tablets
  • generic zaleplon capsules
  • generic zolpidem immediate-release tablets
  • generic zolpidem extended-release tablets
  • generic zolpidem sublingual tablets

Initial criteria

  • If the patient has tried one Step 1 Product, approve a Step 2 Product.
  • If the patient has a documented history of substance use disorder, approve Silenor or generic doxepin 3 mg or 6 mg tablets.
  • If the patient is age ≥ 65 years, approve Silenor or generic doxepin 3 mg or 6 mg tablets.
  • If the patient has difficulty swallowing or cannot swallow tablets/capsules, approve Edluar or Zolpimist.

Approval duration

1 year